These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31255521)

  • 21. Implementation of a medication therapy management collaborative within a pediatric health system.
    Sneed G; Kappeler K; Gilmore T; Kuhn C
    J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time and motion study of pharmacist prescribing of oral hormonal contraceptives in Oregon community pharmacies.
    Frost TP; Klepser DG; Small DC; Doyle IC
    J Am Pharm Assoc (2003); 2019; 59(2):222-227. PubMed ID: 30745187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying Opportunities for Improvement in Safety and Efficacy of Community Pharmacy Immunization Programs.
    Bazzell B; Kelling S; Diez H; Klein K
    J Pharm Pract; 2019 Aug; 32(4):428-433. PubMed ID: 29486666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Forward and backward transitions in pharmacy-based immunization services.
    Westrick SC
    Res Social Adm Pharm; 2010 Mar; 6(1):18-31. PubMed ID: 20188325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacy stages of involvement in pharmacy-based immunization services: results from a 17-state survey.
    Westrick SC; Mount JK; Watcharadamrongkun S; Breland ML
    J Am Pharm Assoc (2003); 2008; 48(6):764-73. PubMed ID: 19019806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facilitating pandemic influenza vaccination implementation in grocery store chain community pharmacies.
    Sutt AR; Pagliaro AM; Wilson E; Renner H; Hall DL; Berenbrok LA; McGivney MS; Coley KC
    J Am Pharm Assoc (2003); 2019; 59(6):848-851. PubMed ID: 31405807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National survey of pharmacy-based immunization services.
    Westrick SC; Patterson BJ; Kader MS; Rashid S; Buck PO; Rothholz MC
    Vaccine; 2018 Sep; 36(37):5657-5664. PubMed ID: 30049631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How involvement of community pharmacies improves accessibility to and awareness about flu vaccination? - An example from Estonia.
    Sepp K; Kukk C; Cavaco A; Volmer D
    Expert Rev Vaccines; 2020 Oct; 19(10):983-990. PubMed ID: 32940097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2022 national survey of immunizing community chain pharmacists: The case for codifying the PREP Act emergency authorities into practice.
    Kulczycki A; Hogue M; Rothholz M; Grubbs J; Shewchuk R
    J Am Pharm Assoc (2003); 2024; 64(1):79-87. PubMed ID: 37863397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A standardized team-based approach for identifying naloxone-eligible patients in a grocery store pharmacy.
    Sexton SM; Armstrong A; Gatton O; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S95-S100. PubMed ID: 31231001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing pharmacy personnel immunization-related confidence, perceived barriers, and perceived influence: The We Immunize program.
    Hastings TJ; Hohmann LA; Huston SA; Ha D; Westrick SC; Garza KB
    J Am Pharm Assoc (2003); 2020; 60(2):344-351.e2. PubMed ID: 31735650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital.
    Mills B; Fensterheim L; Taitel M; Cannon A
    Vaccine; 2014 Jan; 32(4):521-5. PubMed ID: 24269619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic viability of tech-check-tech in an independent community pharmacy.
    Gatwood J; Martin H; Newsome R; Hohmeier KC
    J Am Pharm Assoc (2003); 2019; 59(4):570-574. PubMed ID: 30979577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study.
    Hattingh HL; Sim TF; Parsons R; Czarniak P; Vickery A; Ayadurai S
    BMJ Open; 2016 Sep; 6(9):e011948. PubMed ID: 27650763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Description of the characteristics of pharmacist-based immunization services in North Carolina: results of a pharmacist survey.
    Kummer GL; Foushee LL
    J Am Pharm Assoc (2003); 2008; 48(6):744-51. PubMed ID: 19019803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing use of immunization information systems for routine vaccinations in independent community pharmacies: A randomized controlled trial.
    Hastings TJ; Ha D; Fox BI; Qian J; Lakin J; Westrick SC
    J Am Pharm Assoc (2003); 2022; 62(4):1270-1279.e2. PubMed ID: 35292212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interruptions in community pharmacies: Frequency, sources, and mitigation strategies.
    Reddy A; Abebe E; Rivera AJ; Stone JA; Chui MA
    Res Social Adm Pharm; 2019 Oct; 15(10):1243-1250. PubMed ID: 30420227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacy provision of influenza vaccinations in medically underserved communities.
    Murphy PA; Frazee SG; Cantlin JP; Cohen E; Rosan JR; Harshburger DE
    J Am Pharm Assoc (2003); 2012; 52(1):67-70. PubMed ID: 22257618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective review of the impact of immunization eCare plans in community-based pharmacy setting.
    Snapp A; Gatewood SS; Kaefer TN; Nadpara P; Goode JR
    J Am Pharm Assoc (2003); 2024; 64(2):577-581. PubMed ID: 38151203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of community pharmacist-performed post-discharge medication reviews in transitions of care.
    Tetuan CE; Guthrie KD; Stoner SC; May JR; Hartwig DM; Liu Y
    J Am Pharm Assoc (2003); 2018; 58(6):659-666. PubMed ID: 30056133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.